Schizophrenia is a chronic mental health condition that comprises positive symptoms, negative symptoms, motor symptoms, and a global cognitive deficit. In 2019, schizophrenia ranked as the 20th leading cause of disability globally; affected individuals experience a reduction in life expectancy of 15 years or more. Alongside disease burden, individuals with schizophrenia experience a range of psychiatric and somatic comorbidities. Schizophrenia is reportedly associated with more than 1.5 times the odds of comorbidities across multiple disease categories, and is linked to broad, multi‑system increases in natural‑cause mortality.

This slide deck was developed by Professor Dr.  Merete Nordentoft, Department of Clinical Medicine, University of Copenhagen, Denmark; and Professor Dr. Christoph Correll, Charité – Universitätsmedizin Berlin, Germany, in collaboration with Cambridge (a division of Prime, Cambridge, UK).

Index for
slide deck

Schizophrenia and psychiatric comorbidities

Schizophrenia and psychiatric comorbidities
Schizophrenia and psychiatric comorbidities
file_download Download slide in HQ
Schizophrenia’s hidden genetic relationships
Schizophrenia’s hidden genetic relationships

The authors of this study concluded that the current clinical boundaries between major psychiatric disorders do not reflect distinct underlying genetic aetiologies; many psychiatric disorders, including schizophrenia, share large portions of common variant risk.1 The obse…

file_download Download slide in HQ
Timing of psychiatric comorbidities in schizophrenia
Timing of psychiatric comorbidities in schizophrenia

The figure presents a matrix of HRs showing how receiving one psychiatric diagnosis affects the risk of subsequently receiving another among 5,432 individuals with schizophrenia.1 This analysis captures temporal ordering, that is, which comorbidities tend to appear before…

file_download Download slide in HQ

Related content

image Image Image comparing relapse risk with intermittent versus continuous maintenance therapy in schizophrenia and schizophrenia-like psychoses
Risk of relapse with intermittent therapy versus continuous therapy in schizophrenia and other types of schizophrenia-like psychoses

Continuous maintenance therapy is associated with a lower risk of relapse than intermittent treatment, supporting ongoing treatment strategies in schizophrenia and related psychotic disorders.

06.08.2026 Schizophrenia
image Image Bar chart comparing treatment response rates over time between first and second episodes in Schizophrenia
Changes in 50% response rates over time in first versus second episodes (n=130)

Treatment response tends to be higher during a first episode than during subsequent episodes, emphasizing the importance of early intervention and effective management.

06.08.2026 Schizophrenia
image Image Diagram illustrating the five core domains of negative symptoms in schizophrenia: blunted affect, alogia, anhedonia, asociality, and avolition
Negative symptoms are a core part of schizophrenia

Negative symptoms are a core feature of schizophrenia and can have a profound impact on functioning, social relationships, and quality of life.

06.08.2026 Schizophrenia